J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 88,400 shares at $85.28 ($7.6M) on 2021-07-23, disclosed to the SEC on 2021-07-26.
Open-market sale of $7.6M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.38 | 6,627 | $566K | 7.5% |
| 2 | $85.38 | 6,627 | $566K | 7.5% |
| 3 | $86.19 | 21,773 | $1.9M | 24.7% |
| 4 | $86.19 | 21,773 | $1.9M | 24.7% |
| 5 | $86.90 | 1,600 | $139K | 1.8% |
| 6 | $85.28 | 30,000 |
| $2.6M |
| 33.7% |
| Total | $85.77 avg | 88,400 | $7.6M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |